IBB icon

iShares Biotechnology ETF

883 hedge funds and large institutions have $5.15B invested in iShares Biotechnology ETF in 2024 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 242 increasing their positions, 315 reducing their positions, and 74 closing their positions.

Holders
883
Holders Change
-4
Holders Change %
-0.45%
% of All Funds
12.77%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.14%
New
79
Increased
242
Reduced
315
Closed
74
Calls
$496M
Puts
$810M
Net Calls
-$314M
Net Calls Change
+$658M
Name Market Value Shares Shares
Change
Shares
Change %
WWM
951
Wagner Wealth Management
South Carolina
-75 Closed
EC
952
Elequin Capital
New York
-64 Closed
WIA
953
Wetzel Investment Advisors
Indiana
-51 Closed
CP
954
Castleview Partners
Texas
-28 Closed
NRC
955
New Republic Capital
North Carolina
-25 Closed
RWMG
956
Redwood Wealth Management Group
New Jersey
-15 Closed
PIM
957
Progressive Investment Management
Oregon
-11 Closed
GI
958
Gradient Investments
Minnesota
-9 Closed
ANBT
959
American National Bank & Trust
Texas
-3 Closed
Hudson Bay Capital Management
960
Hudson Bay Capital Management
Connecticut
Capital Fund Management (CFM)
961
Capital Fund Management (CFM)
France
Twin Tree Management
962
Twin Tree Management
Texas
Squarepoint
963
Squarepoint
New York
Allianz Asset Management
964
Allianz Asset Management
Germany
CSS
965
Cubist Systematic Strategies
Connecticut
Balyasny Asset Management
966
Balyasny Asset Management
Illinois
Walleye Trading
967
Walleye Trading
New York
FCM
968
Farallon Capital Management
California
EIM
969
Elliott Investment Management
Florida
C
970
Covestor
United Kingdom
CP
971
Camelot Portfolios
Ohio